
News|Articles|June 29, 2026
AAP updates guidance on pediatric iron deficiency screening and treatment
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Benjamin P. Saylor
New AAP guidance recommends age-specific iron deficiency screening, updated ferritin thresholds, and simplified treatment strategies for children.
Advertisement
Advertisement
Iron deficiency remains one of the most common nutritional deficiencies among children and adolescents in the United States, prompting the American Academy of Pediatrics (AAP) to issue updated recommendations on prevention, screening, diagnosis, and treatment. The new clinical report expands previous guidance by addressing care across infancy through adolescence and incorporates emerging evidence on laboratory evaluation, oral iron dosing, and the role of intravenous iron therapy.
Related to this article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The FDA approved once-weekly somapacitan-beco for growth failure in Turner syndrome in children aged 2.5+ years, based on phase 3 REAL8 data.

Experts explain how puberty affects lipid levels, body composition, and mental health, with implications for cardiovascular screening in adolescent girls.

Experts discuss a new AHA advisory linking cardiovascular risk across a woman's life, from puberty through pregnancy, menopause, and beyond.

In a phase 2 trial, tofacitinib met its safety end point and lowered interferon and cytokine scores in adolescents and adults with Down syndrome.

The FDA approved oral venglustat for neurological symptoms of type 3 Gaucher disease in patients ≥15 kg, based on phase 3 LEAP2MONO data.

Eczema was linked to 28% higher odds of sleep disturbance in a 26,395-patient pediatric primary care cohort presented at ACAAI 2026.
Advertisement
Advertisement

